RxDoctor Payments Data

Peter Fried, MD

Radiation Oncology · Fairfield, OHNPI 1851384671

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $32,690 of the $44,556 with a category attached, or 73.4%. Progenics Pharmaceuticals, Inc. accounts for 83.5% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2023 at $18,859 and has fallen 95.2% since, to $909 in 2025. Among radiation oncology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,556in general payments, 2019–2025

Across 158 payments — averaging $282.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Progenics Pharmaceuticals, Inc.$37K
  • Siemens Medical Solutions USA, Inc.$2K
  • Janssen Scientific Affairs, LLC$674
  • Novartis$539
  • Elekta, Inc.$512
  • Teleflex LLC$458
  • plus $3K from 26 others
$9,875in research payments, 2019–2025

Across 1 payment — averaging $9875.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$10K

What the payments were for

  • Speaking & faculty fees$32,69073%
  • Travel & lodging$5,47712%
  • Food & beverage$6,38914%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,556 in reported general payments places this provider in the 95th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$1,109,546
Medicare patients
366
Services billed
2,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl98$602
Lorazepam13$19

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →